News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Antex Biologics Awarded NIAID Grant To Continue Development Of Helicobacter Pylori Vaccine


10/19/2005 5:08:58 PM

Antex Biologics, a wholly-owned subsidiary of Emergent BioSolutions and sister company to BioPort Corporation, has received a $2 million grant from the National Institute of Allergy and Infectious Disease (a division of the National Institutes of Health) in connection with its Helicobacter pylori (H. pylori) vaccine candidate.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES